Glenmark Pharmaceuticals informs about media release

23 Nov 2020 Evaluate

Glenmark Pharmaceuticals has informed that it enclosed media release titled ‘Recently published data on Favipiravir as treatment for mild to moderate COVID-19 demonstrates significant improvement in time to clinical cure’.

The above information is a part of company’s filings submitted to BSE.

Glenmark Pharma Share Price

1690.95 -2.35 (-0.14%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.